By Jessica Dye ( June 23, 2009, 12:00 AM EDT) -- Sen. Bill Nelson, D-Fla., has introduced legislation in the U.S. Senate to revise the Hatch-Waxman Act's definition of "first applicant" for abbreviated new drug application filers to give generic-drug makers challenging brand-name patents a shot at receiving 180-day market exclusivity....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.